CY2485B1 - Pharmaceutical compositions containing lamivudine and zidovudine. - Google Patents

Pharmaceutical compositions containing lamivudine and zidovudine.

Info

Publication number: CY2485B1
Authority: CY; Cyprus
Prior art keywords: zidovudine; pharmaceutical compositions; compositions containing; containing lamivudine; lamivudine
Prior art date: 1996-10-31

Application number

CY0400085A

Other languages

English (en)

Inventor

Gary Wayne Goodson

Allen Wayne Wood

Katherine Jeannette Ford

Original Assignee

Glaxo Group Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-10-31

Filing date

2004-11-26

Publication date

2005-06-03

2004-11-26 Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd

2005-06-03 Publication of CY2485B1 publication Critical patent/CY2485B1/xx

Links

LHCOVOKZWQYODM-CPEOKENHSA-N 4-amino-1-[(2r,5s)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]pyrimidin-2-one;1-[(2r,4s,5s)-4-azido-5-(hydroxymethyl)oxolan-2-yl]-5-methylpyrimidine-2,4-dione Chemical compound O=C1N=C(N)C=CN1[C@H]1O[C@@H](CO)SC1.O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](N=[N+]=[N-])C1 LHCOVOKZWQYODM-CPEOKENHSA-N 0.000 title 1
239000008194 pharmaceutical composition Substances 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
- A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Virology (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Molecular Biology (AREA)
Chemical Kinetics & Catalysis (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
AIDS & HIV (AREA)
Biotechnology (AREA)
Tropical Medicine & Parasitology (AREA)
Immunology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Saccharide Compounds (AREA)

CY0400085A 1996-10-31 2004-11-26 Pharmaceutical compositions containing lamivudine and zidovudine. CY2485B1 (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GBGB9622681.6A GB9622681D0 (en)	1996-10-31	1996-10-31	Pharmaceutical compositions

Publications (1)

Publication Number	Publication Date
CY2485B1 true CY2485B1 (en)	2005-06-03

Family

ID=10802224

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CY0400085A CY2485B1 (en)	1996-10-31	2004-11-26	Pharmaceutical compositions containing lamivudine and zidovudine.

Country Status (43)

Country	Link
EP (1)	EP0941100B1 (pl)
JP (1)	JP2001502718A (pl)
KR (1)	KR100551652B1 (pl)
AP (1)	AP1067A (pl)
AR (1)	AR009135A1 (pl)
AT (1)	ATE241364T1 (pl)
AU (1)	AU736607B2 (pl)
BG (1)	BG64541B1 (pl)
BR (1)	BR9712614A (pl)
CA (1)	CA2270174A1 (pl)
CO (1)	CO4930269A1 (pl)
CY (1)	CY2485B1 (pl)
CZ (1)	CZ296080B6 (pl)
DE (1)	DE69722433T2 (pl)
DK (1)	DK0941100T3 (pl)
EA (1)	EA002437B1 (pl)
EE (1)	EE03806B1 (pl)
ES (1)	ES2200204T3 (pl)
GB (1)	GB9622681D0 (pl)
GE (1)	GEP20022735B (pl)
GT (1)	GT199700116A (pl)
HR (1)	HRP970569B1 (pl)
HU (1)	HU224969B1 (pl)
ID (1)	ID18698A (pl)
IL (1)	IL129422A0 (pl)
IS (1)	IS5024A (pl)
MY (1)	MY119513A (pl)
NO (1)	NO317163B1 (pl)
NZ (1)	NZ335153A (pl)
OA (1)	OA11038A (pl)
PA (1)	PA8441101A1 (pl)
PE (1)	PE10099A1 (pl)
PL (1)	PL190349B1 (pl)
PT (1)	PT941100E (pl)
SI (1)	SI0941100T1 (pl)
SK (1)	SK284286B6 (pl)
SV (1)	SV1997000090A (pl)
TR (1)	TR199900950T2 (pl)
UA (1)	UA64725C2 (pl)
UY (1)	UY24766A1 (pl)
WO (1)	WO1998018477A2 (pl)
YU (1)	YU19999A (pl)
ZA (1)	ZA979726B (pl)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9622681D0 (en) *	1996-10-31	1997-01-08	Glaxo Group Ltd	Pharmaceutical compositions
GB9809213D0 (en) *	1998-04-29	1998-07-01	Glaxo Group Ltd	Pharmaceutical compositions
US7074417B2 (en) *	2000-10-13	2006-07-11	Advancis Pharmaceutical Corporation	Multiple-delayed release anti-viral product, use and formulation thereof
US20050175694A1 (en) *	2002-04-23	2005-08-11	Himadri Sen	Long acting compositions comprising zidovudine and lamivudine
JP2006508134A (ja) *	2002-11-08	2006-03-09	グラクソ　グループ　リミテッド	医薬組成物
DK1583542T3 (da)	2003-01-14	2008-09-22	Gilead Sciences Inc	Sammensætninger og fremgangsmåder til antiviral kombinationsterapi
AR045841A1 (es) *	2004-09-28	2005-11-16	Richmond Sa Com Ind Y Financie	Una composicion farmaceutica solida que comprende al tiazolil metil ester del acido [5s-(5r, 8r, 10r,11r)] -10- hidroxi-2- metil-5-(1-metiletil)-1-[2-(1-metiletil)-4-tiazolil]-3,6-dioxo-8,11-bis(fenilmetil)-2,4,7,12- tetraazatridecan-13-oico y un procedimiento para prepararla.
CN114010776A (zh)	2010-06-09	2022-02-08	疫苗技术股份有限公司	用于增强抗逆转录病毒治疗的hiv感染者的治疗性免疫
RU2014140177A (ru)	2012-03-05	2016-04-27	Сипла Лимитед	Фармацевтические антиретровирусные композиции
WO2014130553A2 (en) *	2013-02-20	2014-08-28	Abbvie Inc.	Tablet dosage forms
JP2023010676A (ja) *	2021-07-09	2023-01-20	株式会社東洋新薬	固形組成物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4950652A (en) *	1987-03-23	1990-08-21	Hem Research, Inc.	dsRNAs for combination therapy in the treatment of viral diseases
GB9110624D0 (en) *	1991-05-16	1991-07-03	Glaxo Group Ltd	Combinations
WO1992020344A1 (en) *	1991-05-16	1992-11-26	Glaxo Group Limited	Antiviral combinations containing nucleoside analogs
GB9622681D0 (en) *	1996-10-31	1997-01-08	Glaxo Group Ltd	Pharmaceutical compositions

1996
- 1996-10-31 GB GBGB9622681.6A patent/GB9622681D0/en active Pending
1997
- 1997-10-24 HR HR970569A patent/HRP970569B1/xx not_active IP Right Cessation
- 1997-10-28 SV SV1997000090A patent/SV1997000090A/es not_active Application Discontinuation
- 1997-10-28 CO CO97063174A patent/CO4930269A1/es unknown
- 1997-10-28 MY MYPI97005103A patent/MY119513A/en unknown
- 1997-10-29 JP JP10520045A patent/JP2001502718A/ja active Pending
- 1997-10-29 TR TR1999/00950T patent/TR199900950T2/xx unknown
- 1997-10-29 CZ CZ0155799A patent/CZ296080B6/cs not_active IP Right Cessation
- 1997-10-29 SI SI9730570T patent/SI0941100T1/xx unknown
- 1997-10-29 SK SK575-99A patent/SK284286B6/sk unknown
- 1997-10-29 NZ NZ335153A patent/NZ335153A/en unknown
- 1997-10-29 AR ARP970105027A patent/AR009135A1/es unknown
- 1997-10-29 EA EA199900345A patent/EA002437B1/ru not_active IP Right Cessation
- 1997-10-29 AU AU53142/98A patent/AU736607B2/en not_active Ceased
- 1997-10-29 ZA ZA979726A patent/ZA979726B/xx unknown
- 1997-10-29 GE GEAP19974781A patent/GEP20022735B/en unknown
- 1997-10-29 GT GT199700116A patent/GT199700116A/es unknown
- 1997-10-29 HU HU0000344A patent/HU224969B1/hu not_active IP Right Cessation
- 1997-10-29 CA CA002270174A patent/CA2270174A1/en not_active Abandoned
- 1997-10-29 ES ES97950036T patent/ES2200204T3/es not_active Expired - Lifetime
- 1997-10-29 BR BR9712614-4A patent/BR9712614A/pt not_active IP Right Cessation
- 1997-10-29 DK DK97950036T patent/DK0941100T3/da active
- 1997-10-29 PT PT97950036T patent/PT941100E/pt unknown
- 1997-10-29 YU YU19999A patent/YU19999A/sh unknown
- 1997-10-29 PL PL97333143A patent/PL190349B1/pl unknown
- 1997-10-29 PE PE1997000965A patent/PE10099A1/es not_active Application Discontinuation
- 1997-10-29 AT AT97950036T patent/ATE241364T1/de active
- 1997-10-29 DE DE69722433T patent/DE69722433T2/de not_active Expired - Lifetime
- 1997-10-29 EP EP97950036A patent/EP0941100B1/en not_active Expired - Lifetime
- 1997-10-29 UA UA99042239A patent/UA64725C2/uk unknown
- 1997-10-29 WO PCT/EP1997/005953 patent/WO1998018477A2/en not_active Ceased
- 1997-10-29 AP APAP/P/1999/001519A patent/AP1067A/en active
- 1997-10-29 KR KR1019997003757A patent/KR100551652B1/ko not_active Expired - Fee Related
- 1997-10-29 EE EEP199900175A patent/EE03806B1/xx not_active IP Right Cessation
- 1997-10-29 IL IL12942297A patent/IL129422A0/xx not_active IP Right Cessation
- 1997-10-30 PA PA19978441101A patent/PA8441101A1/es unknown
- 1997-10-30 ID IDP973554A patent/ID18698A/id unknown
- 1997-10-30 UY UY24766A patent/UY24766A1/es not_active IP Right Cessation
1999
- 1999-04-09 IS IS5024A patent/IS5024A/is unknown
- 1999-04-23 OA OA9900088A patent/OA11038A/en unknown
- 1999-04-29 NO NO19992091A patent/NO317163B1/no unknown
- 1999-05-26 BG BG103435A patent/BG64541B1/bg unknown
2004
- 2004-11-26 CY CY0400085A patent/CY2485B1/xx unknown

Also Published As

Publication number	Publication date
PT941100E (pt)	2003-10-31
HRP970569B1 (en)	2004-10-31
OA11038A (en)	2002-02-06
NO317163B1 (no)	2004-08-30
BG64541B1 (bg)	2005-07-29
JP2001502718A (ja)	2001-02-27
GT199700116A (es)	1999-04-22
UY24766A1 (es)	2000-12-29
HUP0000344A2 (hu)	2001-05-28
HUP0000344A3 (en)	2002-04-29
CZ155799A3 (cs)	1999-10-13
NO992091D0 (no)	1999-04-29
BR9712614A (pt)	1999-10-26
TR199900950T2 (xx)	1999-07-21
KR20000052893A (ko)	2000-08-25
ES2200204T3 (es)	2004-03-01
HK1020880A1 (en)	2000-05-26
SK284286B6 (sk)	2005-01-03
EA199900345A1 (ru)	2000-02-28
BG103435A (en)	2000-04-28
ID18698A (id)	1998-04-30
AP9901519A0 (en)	1999-06-30
EP0941100B1 (en)	2003-05-28
AU5314298A (en)	1998-05-22
SV1997000090A (es)	1998-10-07
EP0941100A2 (en)	1999-09-15
GB9622681D0 (en)	1997-01-08
PL333143A1 (en)	1999-11-22
DE69722433D1 (de)	2003-07-03
ATE241364T1 (de)	2003-06-15
DK0941100T3 (da)	2003-09-01
MY119513A (en)	2005-06-30
GEP20022735B (en)	2002-07-25
WO1998018477A2 (en)	1998-05-07
YU19999A (sh)	2000-10-30
AP1067A (en)	2002-05-01
DE69722433T2 (de)	2004-04-08
PE10099A1 (es)	1999-03-02
AU736607B2 (en)	2001-08-02
IS5024A (is)	1999-04-09
IL129422A0 (en)	2000-02-17
EE03806B1 (et)	2002-08-15
NO992091L (no)	1999-06-29
NZ335153A (en)	2001-04-27
HRP970569A2 (en)	1998-08-31
WO1998018477A3 (en)	1998-06-18
UA64725C2 (uk)	2004-03-15
ZA979726B (en)	1999-04-29
KR100551652B1 (ko)	2006-02-13
CO4930269A1 (es)	2000-06-27
EA002437B1 (ru)	2002-04-25
EE9900175A (et)	1999-12-15
CZ296080B6 (cs)	2006-01-11
HU224969B1 (en)	2006-04-28
AR009135A1 (es)	2000-03-08
PA8441101A1 (es)	2000-05-24
SI0941100T1 (en)	2003-12-31
SK57599A3 (en)	2000-06-12
CA2270174A1 (en)	1998-05-07
PL190349B1 (pl)	2005-11-30

Publication	Publication Date	Title
ZA975533B (en)	1998-01-29	Cyclosporin-containing pharmaceutical composition.
PL335870A1 (en)	2000-05-22	Hair-care composition
EG24118A (en)	2008-07-06	Pharmaceutical compositions
IL135646A0 (en)	2001-05-20	α-ARYL-N-ALKYLNITRONES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
ZA9710927B (en)	1998-06-15	Pharmaceutical composition.
GB9706089D0 (en)	1997-05-14	Pharmaceutical composition
HUP0001309A3 (en)	2000-12-28	1-phenyl-4-benzylpiperazines and pharmaceutical compositions containing them
IL128058A0 (en)	1999-11-30	Illudin analogs and pharmaceutical compositions containing the same
IL139181A0 (en)	2001-11-25	Homogeneous pharmaceutical compositions comprising abacavir, lamivudine and zidovudine
IL135723A (en)	2005-11-20	1'-Ä4-Ä1-4-Fluorophenyl)-1H-indole-3-ylÜ-1-butylÜ-spiroÄisobenzofuran-1-(3H),4'-piperidineÜhydrohal ogenides and pharmaceutical compositions containing them
CY2485B1 (en)	2005-06-03	Pharmaceutical compositions containing lamivudine and zidovudine.
IL133928A0 (en)	2001-04-30	Pharmaceutical composition containing peptichemio
GB9717444D0 (en)	1997-10-22	Pharmaceutical composition
IL131917A (en)	2001-01-11	Pharmaceutical compositions containing lamivudine
HUP0002455A3 (en)	2001-01-29	Gastric-retained pharmaceutical composition
GB9717428D0 (en)	1997-10-22	Pharmaceutical composition
GB9623962D0 (en)	1997-01-08	Pharmaceutical composition
HUP9903098A3 (en)	2000-01-28	Combination comprising vx478, zidovudine and/or 1592u89 and pharmaceutical composition containing them
GB9717770D0 (en)	1997-10-29	Pharmaceutical composition
GB2321190B (en)	2000-09-20	Pharmaceutical composition
HUP0003528A3 (en)	2001-07-30	Pharmaceutical compositions containing dihydropolyprenols
GB9726781D0 (en)	1998-02-18	Pharmaceutical composition
HUP9602732A2 (en)	1997-09-29	Pharmaceutical composition comprising lanperisone
ZA989436B (en)	1999-04-16	Alpha-aryl-N-alkylnitrones and pharmaceutical compositions containing the same
ZA962792B (en)	1996-12-31	Pharmaceutical composition